Ronald King

Gauzy Ltd. faces potential delisting after recent resignations left its board with zero independent directors, compounding its mounting financial and legal woes.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

City Ventures' new solar-powered townhomes are priced below the median, offering a rare, affordable, and sustainable entry into Orange County's tight market.

With nearly three decades of experience, new president Dan Huynn is tasked with transforming Genstone Insurance into a national powerhouse. Here's his plan.

With a massively oversubscribed bond sale and upgraded credit ratings, Italian API giant FIS solidifies its finances to expand in a booming pharma market.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

With a $60M Series A, Chamber Cardio is using AI and risk-sharing to move cardiology to a value-based model, aiming to fix America's costliest disease.

A nationwide study, with NFL legend Steve Gleason as Participant #1, seeks to uncover why high-performance groups face a disproportionate risk of ALS.

Following a major restructuring, FLSmidth appoints Toni Laaksonen as CEO to accelerate growth and capitalize on its new pure-play mining focus.

South Korean pharma giant Yuyu Pharma invests in James & Ella, the UK's top freeze-dried pet food brand, signaling a major push into the booming pet wellness market.

With $105M in funding and stunning client results, Eudia's 'Augmented Intelligence' is transforming corporate legal from a cost center to a powerhouse.

New data reveals small businesses are leveraging AI-powered PCs to compete with corporate giants, driving a fundamental shift in productivity and strategy.

McCain Foods launches its third 'Farm of the Future' in the UK, showcasing major strides in regenerative agriculture and setting ambitious 2030 climate goals.

From automated bookings to data-driven operations, a new tech tide is rising, promising greater efficiency for operators and better experiences for boaters.

NurExone appoints Eyal Gabbai, a healthcare and finance heavyweight, to its board, signaling a strategic pivot from R&D to market execution for its therapies.

Over 83,000 rural and Indigenous homes in Alberta will gain high-speed internet access through a major federal-provincial funding initiative.

As insurers navigate a digital crossroads, ISG's new study will benchmark over 120 service providers to guide strategic partnership decisions.

Incyte's Zynyz gets a key EU panel's nod, offering a breakthrough for advanced anal canal cancer patients after decades of limited treatment options.

Francisco Partners' acquisition of Jamf for $2.2B marks a new chapter. What does this mean for Apple management, competition, and Jamf's customers?

A new partnership aims to solve the enterprise content explosion by building AI-powered supply chains that promise massive efficiency gains and ROI.